Increased beta-adrenergic sensitivity correlates with visceral hypersensitivity in patients with constipation-predominant irritable bowel syndrome
- PMID: 16110834
- DOI: 10.1007/s10620-005-2860-x
Increased beta-adrenergic sensitivity correlates with visceral hypersensitivity in patients with constipation-predominant irritable bowel syndrome
Abstract
Autonomic imbalance has been proposed to be a pathophysiological factor for irritable bowel syndrome (IBS). The aim of this study was to assess beta-adrenergic abnormalities in IBS and to evaluate their relationship to visceral hypersensitivity and other symptoms of IBS patients. Sixteen IBS patients and 16 control subjects were recruited into this study. Participants were asked to complete a questionnaire regarding bowel symptoms, and in order to study beta-adrenergic sensitivity, isoproterenol stimulation tests were performed and visceral hypersensitivity was evaluated by barostat test. Results showed that beta-adrenergic activity and rectal sensitivity were more pronounced in IBS patients than in normal control patients (P < 0.01). Although both IBS subgroups also exhibited more pronounced beta-adrenergic sensitivity than did the controls (P < 0.05), a significant correlation between beta-adrenergic activity and maximally tolerable pressures on the barostat test was found only in IBS-C patients (P = 0.03, R = 0.855). In addition, patients with "hard or lumpy" stools exhibited a higher degree of beta-adrenergic activity (P = 0.00). We conclude that increased beta-adrenergic activity significantly correlated with visceral hypersensitivity in constipation-predominant IBS and symptoms of hard or lumpy stools in IBS patients.
Similar articles
-
Visceral sensitivity and symptoms in patients with constipation- or diarrhea-predominant irritable bowel syndrome (IBS): effect of a low-fat intraduodenal infusion.Am J Gastroenterol. 2005 Feb;100(2):383-9. doi: 10.1111/j.1572-0241.2005.40100.x. Am J Gastroenterol. 2005. PMID: 15667496
-
[Rectal barostat in irritable bowel syndrome].Rev Med Chil. 2006 Dec;134(12):1524-9. doi: 10.4067/s0034-98872006001200005. Epub 2007 Jan 24. Rev Med Chil. 2006. PMID: 17277868 Spanish.
-
Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome.J Gastroenterol Hepatol. 2006 Jan;21(1 Pt 1):71-8. doi: 10.1111/j.1440-1746.2005.04143.x. J Gastroenterol Hepatol. 2006. PMID: 16706815
-
Brain responses to visceral and somatic stimuli in irritable bowel syndrome: a central nervous system disorder?Gastroenterol Clin North Am. 2005 Jun;34(2):271-9. doi: 10.1016/j.gtc.2005.02.003. Gastroenterol Clin North Am. 2005. PMID: 15862935 Review.
-
Management of irritable bowel syndrome: novel approaches to the pharmacology of gut motility.Can J Gastroenterol. 1999 Mar;13 Suppl A:50A-65A. doi: 10.1155/1999/183697. Can J Gastroenterol. 1999. PMID: 10202210 Review.
Cited by
-
Changes in salivary physiological stress markers induced by muscle stretching in patients with irritable bowel syndrome.Biopsychosoc Med. 2008 Nov 4;2:20. doi: 10.1186/1751-0759-2-20. Biopsychosoc Med. 2008. PMID: 18983682 Free PMC article.
-
Toll-like receptor mRNA expression is selectively increased in the colonic mucosa of two animal models relevant to irritable bowel syndrome.PLoS One. 2009 Dec 9;4(12):e8226. doi: 10.1371/journal.pone.0008226. PLoS One. 2009. PMID: 20011045 Free PMC article.
-
Psychological Co-morbidity in Functional Gastrointestinal Disorders: Epidemiology, Mechanisms and Management.J Neurogastroenterol Motil. 2012 Jan;18(1):13-8. doi: 10.5056/jnm.2012.18.1.13. Epub 2012 Jan 16. J Neurogastroenterol Motil. 2012. PMID: 22323984 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical